As ive said before, when you look at an outbreak, its two Dynamic Forces opposing each other. If you leave the virus to its own devices, it will take off and you can do nothing to stop it. If you put into place the kinds of things that we talk about, first containment and then hopefully you never get to have mitigation but containment is important. Those forces are going to determine whether youre going to have a big outbreak. What dr. Redfield was saying, first of all, is that we will have coronavirus in the fall. I am convinced of that. Because of the degree of transmissibility that it has come of the global nature. What happens with that will depend on how we are able to contain it when it occurs. What we are saying is that in the fall, we will be much, much better prepared to do the kind
of containment compared to what happened to us this winter. The complicating issue is that unlike the syndrome make an influenza like observances that we have, that you could pick it up by clinical
Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma .
These are the best burgers in the Twin Cities startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Liso-Cel for R/R Mantle Cell Lymphoma After 2 Lines of Therapy onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.